March 19, 2018
- Drug Approval Package: ERLEADA (apalutamide)
- Promoting the Use of Complex Innovative Designs in Clinical Trials (updated)
- Non-Compliance Letters under 505B(d)(1) of the Federal Food, Drug, and Cosmetic Act (updated)
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario